Our vision and values
Improving animal health has guided us in the early years of our company’s existence. We believe that research can be directed by the desire to improve human and animal health while being respectful of resources and the environment.
Based on the results obtained in pets on spontaneous cancers, Urodelia is now entering a decisive phase: the development of its personalised treatment in Human oncology.
URODELIA, INNOVATION FOR THE HEALTH OF TOMORROW
We develop innovative therapeutic treatments whose objective is to deliver a very high technological quality.
We excel in innovation to develop our competitiveness and serve the health of tomorrow.
We believe in partnerships to ensure the success and sustainability of the economic health of our business.
Urodelia is part of one of the most promising research pathways in oncology: the immunotherapy.
- Animal health
The treatment is available for veterinary medicine since 2013.
- Human health
A 5-year strategic plan that will lead to the confirmation in humans of the first conclusions obtained in animals